<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02796599</url>
  </required_header>
  <id_info>
    <org_study_id>Exercise-NIV</org_study_id>
    <nct_id>NCT02796599</nct_id>
  </id_info>
  <brief_title>Interfaces of Non-invasive Ventilation on Performance in Patients With Chronic Obstructive Pulmonary Disease</brief_title>
  <acronym>Exercise-NIV</acronym>
  <official_title>Impact of Various Interfaces of Non-invasive Ventilation on Performance During Exercise in Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ADIR Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ADIR Association</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine wether the interface (facial or nasal mask)
      influences performance in patients with chronic obstructive pulmonary disease exercising with
      non-invasive ventilation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endurance time (Tlim, in second) during Constant Work Load Test (CWLT).</measure>
    <time_frame>The outcome will be measure after every CWLT. The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
    <description>Patients will achieve 3 Constant Work Load Test Under different conditions (1 without noninvasive ventilation and 2 with noninvasive ventilation using in a randomised order facial or nasal mask). Endurance time (sec) will be recorded at the end of every test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort of different masks using numerical scale (0-10) after exercising with noninvasive ventilation.</measure>
    <time_frame>The outcome will be measure after every CWLT achieved with noninvasive ventilation. CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
    <description>The comfort of the different interfaces is assessed after every CWLT using numerical scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea during CWLT using modified Borg Scale (0-10).</measure>
    <time_frame>The outcome will be measure during every CWLT.The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum. Data will be collected every 30s during tests.</time_frame>
    <description>The dyspnea will be assessed every 30sec during CWLT. Results will be shown at Tlim (Tlim for the 3 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exhaustion during CWLT using modified Borg Scale (0-10).</measure>
    <time_frame>The outcome will be measure during every CWLT.The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum. Data will be collected every 30s during tests.</time_frame>
    <description>The exhaustion will be assessed every 30sec during CWLT. Results will be shown at Tlim (Tlim for the 3 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate (rpm) during CWLT using capnograph.</measure>
    <time_frame>The outcome will be measure during every CWLT (with or without noninvasive ventilation).The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum. Data will be continuously collected.</time_frame>
    <description>Outcome will be continuously recorded. Results will be shown at Tlim (Tlim for the 3 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (mmHg) before and after every CWLT using electrical blood pressure device.</measure>
    <time_frame>The outcome will be assessed before and after every CWLT. The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation (SpO2, %) during CWLT using capnograph.</measure>
    <time_frame>The outcome will be measure during every CWLT (with or without noninvasive ventilation).The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum. Data will be continuously collected.</time_frame>
    <description>Outcome will be continuously recorded. Results will be shown at Tlim (Tlim for the 3 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous carbon dioxide pressure (PtcCO2, mmHg) during CWLT using capnograph.</measure>
    <time_frame>The outcome will be measure during every CWLT (with or without noninvasive ventilation).The 3 CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum. Data will be continuously collected.</time_frame>
    <description>Outcome will be continuously recorded. Results will be shown at Tlim (Tlim for the 3 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate (rpm) during CWLT with noninvasive ventilation using ventilator monitoring.</measure>
    <time_frame>The outcome will be measure during CWLT with noninvasive ventilation. CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
    <description>Outcome will be continuously recorded. Results will be shown at Tlim (Tlim for the 2 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory tidal volume (Vti, in liter) during CWLT with noninvasive ventilation using ventilator monitoring.</measure>
    <time_frame>The outcome will be measure during CWLT with noninvasive ventilation. CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
    <description>Outcome will be continuously recorded. Results will be shown at Tlim (Tlim for the 2 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leak (liter per minute) during CWLT with noninvasive ventilation using ventilator monitoring.</measure>
    <time_frame>The outcome will be measure during CWLT with noninvasive ventilation. CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
    <description>Outcome will be continuously recorded. Results will be shown at Tlim (Tlim for the 2 tests) and iso time (defined as the Tlim or the shortest test).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Ventilatory asynchronism during CWLT with noninvasive ventilation using ventilator monitoring.</measure>
    <time_frame>The outcome will be measure during CWLT with noninvasive ventilation. CWLT will be carried out in different days, separate from 1 day minimum for a total time frame of 2 weeks maximum.</time_frame>
    <description>Outcome will be continuously recorded.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Non Invasive Ventilation</condition>
  <condition>Exercise, Aerobic</condition>
  <arm_group>
    <arm_group_label>CWLT with facial mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study has a cross-over design. Patients will achieve CWLT with non-invasive ventilation using facial or nasal mask in a randomised order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CWLT with nasal mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study has a cross-over design. Patients will achieve CWLT with non-invasive ventilation using facial or nasal mask in a randomised order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non invasive ventilation during exercise with facial or nasal mask.</intervention_name>
    <description>Every patients will achieve 3 constant work load test (CWLT) at 75% Wpic. The first CWLT will be realized without any ventilatory support. The 2 others CWLT will be achieved with non-invasive ventilation support using facial or nasal interface in a randomized order.</description>
    <arm_group_label>CWLT with facial mask</arm_group_label>
    <arm_group_label>CWLT with nasal mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Chronic obstructive pulmonary disease Gold III-IV

          -  Eligible for pulmonary rehabilitation

          -  Exercise limitation : at least respiratory limitation (ventilatory reserve ≤ 30%)

        Non-inclusion Criteria:

          -  Pregnant woman or likely to be

          -  Familiar with home non-invasive ventilation

          -  Patient under guardianship

        Exclusion Criteria:

          -  Acute exacerbation of chronic obstructive pulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Viacroze, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de pneumologie, Bois-Guillaume, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Catherine Tardif, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de physiologie urinaire, digestive, respiratoire et sportive, Bois-Guillaume, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Debeaumont, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de physiologie urinaire, digestive, respiratoire et sportive, Bois-Guillaume, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-François Muir, Prof, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU-Hôpitaux de Rouen - Service de pneumologie, Hôpital de Bois-Guillaume, Rouen, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France ; ADIR Association, Bois-Guillaume, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tristan Bonnevie, PT, MsC</last_name>
    <role>Study Chair</role>
    <affiliation>ADIR Association, Bois-Guillaume, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis-Edouard Gravier, PT</last_name>
    <role>Study Chair</role>
    <affiliation>ADIR Association, Bois-Guillaume, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clément Médrinal, PT, MsC</last_name>
    <role>Study Chair</role>
    <affiliation>UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France. Service de réanimation, Groupe Hospitalier du Havre, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ADIR Association</name>
      <address>
        <city>Bois-Guillaume</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2016</study_first_submitted>
  <study_first_submitted_qc>June 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2016</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

